Ana Laura Mendoza
Ana Laura Mendoza is a patient diagnosed with rheumatoid arthritis who has been prominently featured in the news due to her desperate struggle to obtain essential medication, specifically Adalimumab, which she has not received since May. Her case highlights the severe shortages of critical drugs in the Instituto de Previsión Social (IPS), forcing patients to seek expensive alternatives or rely on community support.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Paraguay | 2 | 5.00 | 0.20% | +0% | 7,132,538 | 13,999 | $38,000 | 75$ |
| Totals | 2 | 7,132,538 | 13,999 | $38,000 | 75$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Paraguay:
Ana Laura Mendoza expressed her struggle to afford her arthritis medication, which costs G. 29,500,000.
5
Paraguay:
Ana Laura Mendoza, a patient diagnosed with rheumatoid arthritis, reported that she has not received her essential medication since May.
5